Friday 13 November 2026
MICROREGISTRAR · INFECTION INTELLIGENCE — Daily Infection Update
This summary is an AI-assisted aggregation of published sources. Always read the original article via the link before acting on anything here. For academic use only, not clinical advice.
01 Executive Summary
- Confirmed Defra / APHA · HPAI · 12–13 Nov
1 England AIPZ now includes housing measures from 00:01 on 13 November; new H5N1 case near Dereham, Norfolk
The England-wide AIPZ was updated on 12 Nov (16:25 GMT) to add mandatory housing measures, in force from 00:01 today. Keepers of 50 or more birds must house them; keepers of fewer than 50 must house them if they sell or give away eggs, poultry products or live birds. A welfare exemption route exists for ducks, geese, swans, ratites and game-restocking poultry. Separately, HPAI H5N1 was confirmed in commercial poultry near Dereham, Breckland, Norfolk (AIV 2026/28) on 12 Nov, with 3 km and 10 km zones declared.
Inconsistent wording on the source page: The GOV.UK summary line for the Dereham case (AIV 2026/28) says H5N1 was confirmed “near Market Rasen, West Lindsay, Lincolnshire”, while the page body says “near Dereham, Breckland, Norfolk”. We have used the body text and case number; the summary line looks like a carry-over from the Market Rasen page (AIV 2026/27).
GOV.UK AIPZ (England) › · Housing guidance › · Dereham case page ›
- Confirmed UKHSA · ESPAUR 2025–26 · 12 Nov
2 ESPAUR 2025–26: 21,129 antibiotic-resistant bacteraemias in England in 2025 (average 406 a week)
Up 16.8% on 2019 (18,086) and 3.2% on 2024 (20,468); the year-on-year rise has slowed (9.3% between 2023 and 2024). Total NHS antibiotic use fell 10.7% between 2019 and 2025 (17.8 to 15.9 DID). Estimated deaths among people with a resistant Gram-negative bacteraemia were 2,318 in 2025 (2,399 in 2024). UKHSA says deprived communities and older people are hit hardest.
Figures from the UKHSA press release: All figures here are taken from the UKHSA news story; we have not checked them against the full ESPAUR report tables this morning. The press release uses defined daily doses per 1,000 inhabitants per day (DID) for antibiotic use.
- Confirmed UKHSA · MenB · 12 Nov
3 One-off MenB catch-up: only 28.2% of 18–19-year-olds have had a first dose; deadline 31 December
To 31 Oct, 228,297 of 809,957 eligible 18–19-year-olds had dose 1, and 68.8% of those had dose 2. UKHSA cites several MenB outbreaks in England this year and three deaths. First doses end on 31 Dec 2026; second doses (at least 28 days apart) remain available to 31 Mar 2027. Uptake data for older first-year students up to age 25 are not yet available.
- Confirmed UKHSA · respiratory surveillance · week 45
4 Flu rising from a low level in England; RSV hospital activity up to low levels
Week 45 (2–8 Nov): flu positivity 8.1% (7.8% the week before); flu hospital admissions 3.65 per 100,000 (3.00). COVID-19 stable at low levels (positivity 7.2%; admissions 2.22 per 100,000). RSV admissions 1.30 per 100,000 (0.89). Syndromic surveillance showed small increases in some acute respiratory infection indicators.
- Confirmed WHO · Tuberculosis · 12 Nov
5 WHO Global TB Report 2026: an estimated 10.6 million people developed TB in 2025 and about 1.1 million died
Deaths are down 35% since 2015, meeting the End TB Strategy’s first mortality milestone five years late; incidence is down only 14% against a 50% milestone for 2025. Domestic TB funding rose 14% to US$5.6 billion between 2024 and 2025, partly offsetting a similar fall in international funding.
Microregistrar Moodle update
Today’s update
Read directly from the MoodleCloud Google Sheet Index tab (“Whats new?” column) on the morning of 13 Nov.
Nothing new today. The newest rows are still dated 10/11/2026 (Hepatitis C; Renal drug dose adjustment), reported in the 11 Nov issue. Sheet ›
Content list
The public content list is the Microregistrar Moodle Google Sheet, linked from the Moodle page on microregistrar.com (wording: “You can find a list of content in this spreadsheet”). The daily update above is taken from the Index tab (“Whats new?”) of the same spreadsheet, which is the tab previous newsletter issues have used.
Content list (spreadsheet) › · Index / What’s new tab › · microregistrar.com Moodle page ›
What is Microregistrar Moodle
Microregistrar.moodlecloud.com is an online learning platform for doctors preparing for the FRCPath Medical Microbiology examinations. It provides structured revision support for Part 1 and Part 2, including core microbiology topics, high-yield notes, exam-focused questions, guideline and UKHSA updates, laboratory interpretation material, and practical study guidance.
The same page says it includes material curated and written by experienced UK microbiologists; interactive high-yield notes; regular updates on guidelines and important studies; updates from the Health Protection Report; guidance for Part 1 and Part 2; an active members-only WhatsApp group; approximately 500 FRCPath Part 1-style MCQs with answers and explanations; more than 100 Part 2 questions with model answers; and a standing Part 2 mock examination. It also states that the group at present has >400 members from various parts of the world and, over the last 3 years, has supported >700 members. Approved members can access course materials after enrolment.
Wording taken from microregistrar.com/microregistrar-moodle-frcpath/ (checked 13 Nov 2026; fees unchanged). The Moodle front page itself returned 403 to our fetch, so it was not used as a source.
How to subscribe / join
The public Moodle page on microregistrar.com is headed “How to register for Moodle?” It states: “Access to Microregistrar is by application. Applicants are reviewed to ensure the platform remains focused on postgraduate medical training.” The application process, as printed, is:
- Fill in this form: https://forms.gle/HaqeVqLgGx2hH5Xy7
- Send an email that you have filled in the application form to microregistrar@gmail.com
- “I shall send you more information, the payment link, and further instructions.”
Membership fee (as printed on that page): 6 months – £58.5; 1 year – £99.0. “There is no autorenewal. If you want to renew, follow the above process and contact me.”
Taken from microregistrar.com/microregistrar-moodle-frcpath/ (checked 13 Nov 2026; fees unchanged). moodlecloud.com/login/signup.php and the Moodle front page returned 403 to our fetch, so we could not verify whether a signup form on the Moodle site itself matches this process.
02 UK Infection Updates
UKHSA, the UKHSA dashboard, NHS England, PHS, PHW, NI PHA, Ireland HPSC, NICE and national events. The AIPZ housing measures are written up under 07 One Health, ESPAUR under 04 AMR Watch, and MenB and MMRV under 06 Vaccines & Medicines.
Winter respiratory surveillance, England (2–8 Nov)
Flu: activity increased and is circulating at low levels; laboratory positivity 8.1% (7.8%); hospitalisation rate 3.65 per 100,000 (3.00). COVID-19: stable and low; positivity 7.2% (7.4%); admissions 2.22 per 100,000 (2.23); ICU/HDU admissions 0.07 per 100,000 (0.05). RSV: hospital activity increased to low levels; positivity 3.2% (2.9%); admissions 1.30 per 100,000 (0.89). Norovirus (weeks 44–45): laboratory reports 8.7% below the five-season average; rotavirus 25% above it. UKHSA will resume HNORS hospital norovirus outbreak data on 26 Nov. Syndromic surveillance (UKHSA bulletin, also forwarded by Mail Sorter) reported small increases in some acute respiratory infection indicators.
Date typo on the source page: The UKHSA page labels the norovirus period “26 November to 8 November 2026” in one heading and “26 October 2026 to 8 November 2026” in the text. The October date is the correct one for weeks 44–45.
Measles, England: 1,055 laboratory-confirmed cases in 2026 to 9 November
25 more cases since the 15 Oct update; 17 cases with onset in the four weeks since 12 Oct. Activity peaked in May (215 cases) and has since stabilised at a low level. 61% of cases were in children aged 10 or under; 51% were in London, with the highest numbers in Enfield (111), Birmingham (82) and Hertfordshire (64). Three measles-related deaths have been reported in 2026. Next update 10 Dec.
Mpox, UK: clade Ib now more common than clade IIb
Monthly overview, data to 31 Oct (extracted 9 Nov). From 1 Jan 2023 to 31 Oct 2026, 1,389 UK cases of mpox (all clades): clade Ib 298, clade IIb 979, clade not yet known 112. UKHSA says clade Ib cases have exceeded clade IIb cases each month since July 2026, mainly through community transmission in GBMSM networks, with an increase in cases in the north of England in early 2026.
Outbreaks under monitoring, week 45; Ebola case-location page updated
UKHSA’s weekly summary for HCID clinicians (published 12 Nov) covers Bundibugyo virus disease (DRC 11,042 cases and 5,387 deaths as of 9 Nov; North Kivu’s 7-day average of new cases now above Ituri’s) and human A(H9N2) cases in China. UKHSA continues to assess the risk to the UK population as low. The Ebola and Marburg case-locations page now includes the medically evacuated UK case.
NHS England, devolved nations, Ireland and NICE
Nothing else new today. NI PHA’s MMRV catch-up is under 06 Vaccines & Medicines. NHS England’s 12 Nov news (elective performance; anal cancer treatment) is not infection-related, nor is NICE’s 12 Nov guidance (HTG786). No new PHW or HPSC item was found; PHS pages need JavaScript and were not read.
UKHSA dashboard › · PHS › · PHW › · NI PHA › · HPSC ›
03 Global Outbreaks
WHO DON, ECDC, CDC, WHO AFRO, PAHO and WHO SEARO. Only items with a material development in the window are written up.
WHO Global Tuberculosis Report 2026
Released 12 Nov, based on data from 187 countries and areas. An estimated 10.6 million people developed TB in 2025 and 1.13 million died (rounded to 1.1 million in the press release). Deaths have fallen 35% since 2015, reaching the first End TB Strategy mortality milestone five years late; incidence has fallen 14% against the 50% milestone for 2025. Domestic funding rose 14% to US$5.6 billion. WHO advises against comparing burden estimates directly with earlier editions.
Bundibugyo Ebola: DRC reaches 11,114 confirmed cases; WHO says South Sudan importation risk now 99%
DRC. ECDC (12 Nov): 11,114 confirmed cases including 5,433 deaths (data to 10 Nov), 72 cases and 46 deaths more than the previous update; new cases in Ituri (44), Nord-Kivu (24), Haut-Uélé (3) and Nord Ubangi (1). 85.5% of identified contacts under follow-up. Kenya: unchanged (nine cases, two deaths; all contacts completed 21 days of quarantine). ECDC still rates the likelihood of infection as low for EU/EEA travellers and very low for people living in the EU/EEA. South Sudan. WHO AFRO (12 Nov): no confirmed case, but its estimate of importation risk has risen from 67% (June) to 99% (October); a September assessment counted 3,450 people crossing from DRC. Ebola was item 1 on 7 Nov, so it does not lead today.
Do not merge figures: These ECDC totals (data to 10 Nov) replace yesterday’s ECDC figures (11,042 cases / 5,387 deaths, data to 9 Nov). UKHSA’s Outbreaks under monitoring week 45 still quotes the 9 Nov figures. WHO’s newest Disease Outbreak News is still DON625 (6 Nov). The UKHSA report says Kenya has had no new case since 19 Oct; ECDC says the last case was reported on 20 Oct.
West Nile virus 2026: the largest and most widespread EU/EEA season on record
ECDC monthly report (12 Nov): as of 4 Nov, 15 EU/EEA countries reported 1,883 locally acquired human cases (decade average for the period 698) and 148 deaths, across 211 NUTS 3 regions. Italy (783), Greece (469) and France (191) reported most cases; Belgium reported its first human infections. 76% of cases were hospitalised. Activity has declined since the August–September peak.
WHO DON, CDC, PAHO and SEARO
Nothing else new today. No Disease Outbreak News after DON625 (6 Nov). PAHO’s epidemiological alerts page showed no item dated in the window. CDC travel notices showed nothing new; CDC HAN, MMWR and measles pages returned an error page to our fetch.
04 AMR Watch
WHO GLASS, ECDC AMR, UKHSA, EUCAST and SAPG.
ESPAUR 2025–26 published: resistant infections still rising, but more slowly
Published 12 Nov (09:30 GMT). Resistance: 21,129 antibiotic-resistant bacteraemia cases in England in 2025 (average 406 a week), up 16.8% from 18,086 in 2019 and 3.2% from 20,468 in 2024; the 2023–24 rise was 9.3%. Deaths: an estimated 2,318 deaths among people with a resistant Gram-negative bacteraemia in 2025 (2,399 in 2024). Use: total NHS antibiotic use fell 10.7% between 2019 and 2025, from 17.8 to 15.9 DID; private prescriptions dispensed in community pharmacies (not in the NHS total) fell 20.8% between 2024 and 2025, from 0.61 to 0.48 DID. UKHSA says the most deprived communities and older people are hit hardest.
Figures from the UKHSA press release: All figures here are taken from the UKHSA news story; we have not checked them against the full ESPAUR report tables this morning. The press release uses defined daily doses per 1,000 inhabitants per day (DID) for antibiotic use.
UKHSA review of antimicrobial resistance in Listeria in the food chain
Published 12 Nov at the Food Standards Agency’s request: a literature review of food-chain L. monocytogenes isolates (studies 2020–2024, all six WHO regions) looking for any increase in resistance to penicillins, aminoglycosides, carbapenems and co-trimoxazole. Read the report for its conclusions; we have not summarised them here.
WHO third edition of the M. tuberculosis drug-resistance mutation catalogue (10 Nov)
WHO published the third edition of its Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance on 10 Nov, a reference for interpreting molecular and sequencing-based resistance testing. Catch-up: it was missed in the 11 and 12 Nov issues.
Nothing else new today. EUCAST news and SAPG show no new dated item. WHO GLASS and ECDC AMR pages showed no item dated in the window.
05 IPC Watch
HIS, NHS England, UKHSA and CDC, covering healthcare-associated outbreaks, transmission incidents and IPC guidance.
Nothing new today. HIS news showed no item dated in the window. No healthcare-associated outbreak or transmission incident was confirmed from a primary source. UKHSA will resume publishing HNORS hospital norovirus outbreak data on 26 Nov.
06 Vaccines & Medicines
JCVI, Green Book, WHO immunisation, MHRA, FDA, EMA and NICE.
Low uptake in the one-off MenB programme for young adults
Coverage to 31 Oct 2026: 28.2% of 18–19-year-olds (228,297 of 809,957; born 1 Sep 2007 to 31 Aug 2008) have had dose 1; 68.8% of them (157,169) have had dose 2. The offer also covers people under 25 starting university or residential further education for the first time this autumn; their uptake data are due in the coming months. First doses close on 31 Dec 2026; second doses, at least 28 days after the first, are available until 31 Mar 2027. UKHSA cites several MenB outbreaks in England this year and three deaths. ICB, region, IMD, ethnicity and sex breakdowns are in the coverage report.
Northern Ireland: selective MMRV catch-up for children born 1 Jan 2020 to 31 Aug 2022
NI PHA (12 Nov): running from 1 Nov 2026 to 31 Mar 2028, a single MMRV dose for children in this cohort who have not had chickenpox or two doses of varicella vaccine. MMRV replaced MMR in the routine schedule in January 2026 for children born on or after 1 Sep 2022.
JCVI, Green Book, MHRA, FDA, EMA, NICE, WHO immunisation
Nothing else new today. No new JCVI statement or Green Book chapter. MHRA’s only alert in the window (Class 4 defect, enalapril/hydrochlorothiazide) is not an infection product. FDA and EMA news pages showed no infection item dated in the window.
07 One Health
WOAH, FAO and APHA/Defra, including avian influenza and zoonoses.
England AIPZ: mandatory housing measures from 00:01, 13 November
Defra updated the England-wide AIPZ on 12 Nov (16:25 GMT) to add housing measures from 00:01 on 13 Nov. The new declaration revokes and replaces the one made at 23:30 on 10 Nov (in force 09:00, 11 Nov). Who must house: keepers of 50 or more birds of any type; keepers of fewer than 50 birds who sell or give away eggs, poultry products or live birds; and anyone in a protection zone or captive bird (monitoring) controlled zone. Keepers of fewer than 50 birds kept only for their own use do not have to house them. Exemptions: keepers of ducks, geese, swans, ratites or poultry kept for restocking game may seek a welfare exemption with their vet. Housing guidance updated at 00:01 today covers welfare (stocking, light, ventilation, temperature, enrichment).
Scotland, Wales and Northern Ireland not checked for housing: We found no Scottish Government news item on housing in the window; Wales and Northern Ireland were not checked.
GOV.UK AIPZ (England) › · Housing guidance › · England situation ›
Dereham, Breckland, Norfolk: HPAI H5N1 in commercial poultry (AIV 2026/28)
Confirmed 12 Nov (GOV.UK, 18:18 GMT). 3 km protection and 10 km surveillance zones declared; all poultry on the premises to be culled. Recent England commercial cases: Garstang and Pocklington (7 Nov), Dersingham (9 Nov), Market Rasen (11 Nov), now Dereham.
Inconsistent wording on the source page: The GOV.UK summary line for the Dereham case (AIV 2026/28) says H5N1 was confirmed “near Market Rasen, West Lindsay, Lincolnshire”, while the page body says “near Dereham, Breckland, Norfolk”. We have used the body text and case number; the summary line looks like a carry-over from the Market Rasen page (AIV 2026/27).
WOAH and FAO
Nothing new found. The WOAH what’s-new page showed no item dated in the window; FAO was not checked.
08 Innovation & Technology
MHRA, FDA, FIND, and company announcements only when verified against regulators.
Nothing new today. No infection-related MHRA device or FDA approval in the window. FIND’s newsroom showed no item dated in the window.
09 Other Notable News
Short headlines with original links. CIDRAP, BMJ News and STAT are discovery sources, traced to a primary page where possible.
Oregon reports its first H5N1 detection in dairy cows
CIDRAP (12 Nov, 15:00 GMT) reports Oregon’s first H5N1 case in cows, and a farmers’ union claim that human avian flu cases are under-reported in Washington State.
Secondary source only: We did not trace this to an Oregon Department of Agriculture or USDA APHIS page before cut-off. The under-reporting claim is the union’s, not an official finding.
Not used: a CIDRAP vaccine-policy column on US measles elimination and a Florida COVID-19 vaccine study (opinion and journal content). BMJ News and STAT were not scanned this morning.
Continuing stories tracker
An ongoing story reappears in the daily sections only if cases, geography, risk or control measures change materially.
| Story | First reported | Today’s status | What changed |
|---|---|---|---|
| England / GB HPAI (2026–27 season) | 5 Nov 2026 issue (Brigg, AIV 2026/23) | Yes | Control measures: England AIPZ housing measures from 00:01, 13 Nov. New case: Dereham, Norfolk (AIV 2026/28, 12 Nov). |
| DRC Bundibugyo Ebola | Outbreak declared 15 May 2026; last newsletter lead 7 Nov | Yes | DRC 11,114 cases / 5,433 deaths (ECDC, data to 10 Nov). WHO AFRO puts South Sudan’s importation risk at 99%. Kenya countdown continues (day 2 today). Not item 1 (led 7 Nov). |
| UK Ebola medevac (Royal Free) | 7 Nov 2026 issue | No | Case added to UKHSA’s case-locations page; no clinical update. |
| ESPAUR 2025–26 | Announced in 12 Nov issue (due 12 Nov) | Yes | Published 12 Nov. |
| Yellow fever, WHO African Region | 7 Nov 2026 issue (DON624) | No | No new WHO update; UKHSA Global Hazards bulletin (5–11 Nov, via Mail Sorter) adds nothing new. |
| US A(H5) in people and cattle | 10 Nov 2026 issue (Yakima County) | Yes (secondary) | CIDRAP reports Oregon’s first H5N1 detection in cows; not yet traced to a primary source. |
| Human H9N2, mainland China | 11 Nov 2026 issue (CHP week 45) | No | UKHSA week 45 summary repeats the two cases in children; no new cases. |
| US measles elimination status | 11 Nov 2026 issue (CIDRAP) | No | No PAHO decision found. |
What we could not confirm
Source-access and coverage limits only. Doubts about a specific item are in a yellow note under that item.
| Source | Issue |
|---|---|
| Compilation window | Cut-off 06:12 Europe/London (GMT) on 13 Nov for 07:00 publication. Anything released after this is not in today’s issue. |
| CDC | HAN, MMWR and measles pages returned an error page to our fetch. |
| FAO, WHO SEARO | FAO not checked; the WHO SEARO news page showed no dated item to our fetch. |
| UKHSA dashboard | Not opened; respiratory figures come from the UKHSA weekly surveillance news page. |
| PHS / PHW / HPSC | PHS pages need JavaScript and were not read; PHW and HPSC pages showed no item dated in the window (HPSC epidemiological reports paused during work stoppages, notice 13 Oct). |
| Devolved AIPZ housing | Housing status in Scotland, Wales and Northern Ireland not confirmed. |
| ESPAUR | Figures taken from the UKHSA press release; full report tables not checked. |
| Oregon H5N1 in cows | CIDRAP only; not traced to a state or USDA source. |
| BMJ News, STAT | Not scanned this morning. |
Not out yet
- WHO: any Disease Outbreak News after DON625; a reconciled Ebola tally.
- UKHSA: HNORS hospital norovirus outbreak data (resumes 26 Nov); MenB uptake for students aged up to 25.
- PAHO: outcome of the measles Re-Verification Commission meeting.
- Defra: an outbreak assessment that includes the November England cases.
About this issue
Counted without journals (Journal Watch owns journals). The UK count covers: AIPZ housing update, housing guidance, Dereham case (Defra/APHA); ESPAUR, Listeria AMR review, MenB news, MenB coverage, winter surveillance, syndromic summary, measles, mpox, Outbreaks under monitoring, Ebola/Marburg case locations (UKHSA); MMRV catch-up (NI PHA). The ECDC item is the 12 Nov Ebola/WNV public health event updates.
Compilation metadata, editorial rules and the source list. Doubts about a specific item are marked in a yellow note under that item.
MICROREGISTRAR · INFECTION INTELLIGENCE — Daily Infection Update for 13 November 2026. The top developments are in 01 Executive Summary, UK first; full write-ups sit in the numbered sections. Nothing has been invented, and a quiet section is left short rather than padded.
Editorial rules applied: last 24 hours prioritised · UK first · primary-source link on every item · labelled Confirmed / Investigation / Preliminary / Unverified · no recycling without a material change · no artificial quotas · a quiet section reads “Nothing new today” · Ebola may lead at most once in seven days (last led 7 Nov) · no journals and no X checks.
Sources
What we checked for this issue, before the 06:12 cut-off on 13 Nov.
- GOV.UK search and content APIs for UKHSA, MHRA, DHSC, Defra and APHA (AIPZ, housing guidance, Dereham case, ESPAUR, MenB, winter surveillance, measles, mpox, Outbreaks under monitoring)
- Scottish Government news; NI PHA news
- Microregistrar MoodleCloud Google Sheet (Index tab), read directly through the Sheets connector; microregistrar.com Moodle page (fees re-checked)
- WHO Disease Outbreak News API (newest DON625); WHO news API (Global TB Report 2026; TB mutation catalogue); WHO AFRO news
- ECDC public health events (12 Nov Ebola and WNV updates), ECDC newsroom, ERVISS, ECDC AMR
- CDC travel notices (readable); CDC HAN, MMWR and measles (error pages)
- User-approved daily nine: PHS (not read), PHW, NI PHA, HPSC, ECDC ERVISS, EUCAST news, SAPG, HIS news, PAHO epidemiological alerts
- NHS England news, NICE published guidance, FDA press announcements, EMA news, WOAH, FIND, WHO SEARO, WHO GLASS, Africa CDC
- CIDRAP per-topic feeds (Ebola 64, measles 78, avian flu 49, AMS 48, influenza 69, HAI 81141, COVID-19 178636, pertussis 87, mpox 230556, C. auris 232685), traced to primary sources where possible
- Mail Sorter / microregistrar2021@gmail.com, last day: UKHSA Syndromic Surveillance Summary week 45 (12 Nov) and UKHSA Global Hazards Weekly Bulletin 5–11 Nov (no new item)
- Live site baseline: microregistrar.com/newsletter/ (12 Nov issue) and local 2026-11-12.html
